P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.

Marco ValgimigliFelice GragnanoMattia BrancaAnna FranzoneUsman BaberYangsoo JangTakeshi KimuraJoo-Yong HahnQiang ZhaoStephan WindeckerCharles M GibsonByeong-Keuk KimHirotoshi WatanabeYoung Bin SongYunpeng ZhuPascal VranckxShamir MehtaSung-Jin HongKenji AndoHyeon-Cheol GwonPatrick W SerruysGeorge D DangasEùgene P McFaddenDominick J AngiolilloDik HegPeter JüniRoxana Mehran

Published in: BMJ (Clinical research ed.) (2021)

PROSPERO CRD42020176853.

Keyphrases

antiplatelet therapy
percutaneous coronary intervention
acute coronary syndrome
coronary artery disease
coronary artery
case report
combination therapy
open label
heart failure
clinical trial
aortic stenosis
atrial fibrillation
aortic valve